Sofus Regulatory Affairs is provides regulatory affairs services for all phases of the pharma and biotech development.
Sofus Regulatory Affairs AB | 717 followers on LinkedIn. Sofus Regulatory Affairs is now ProPharma Group. Follow ProPharma Group on LinkedIn for company
Region Sverige. Telefon: 08 - 215445. Tjänster. Nyhetsbrev Company profile page for Sofus Regulatory Affairs AB including stock price, company news, press releases, executives, board members, and contact information Regulatory Affairs Sofus offers services in European regulatory affairs. We believe that a reliable expertise in regulatory affairs is the most important factor in reaching the market successfully. Our driving force is to use our expertise to reduce regulatory risks in all parts of the product life cycle.
- Pinnacle affiliates
- Vuxenutbildning uddevalla lediga jobb
- Lycamobile sverige internet
- Anställningsbarhet perspektiv från utbildning och arbetsliv.
Sofus has specialized in regulatory affairs in pharmaceuticals since 2002. Be it Development Services or Post-Approval Services, we supply comprehensive regulatory, quality and safety solutions. No matter whether you're a multinational corporation or a small business – we can help you shorten the time and distance between your product and the patient. From clinical to commercialization, and every point in between, we partner with pharmaceutical, biotechnology, and medical device clients to ensure regulatory expectations are met, business goals are achieved, and patient safety is protected. Sofus provides the full spectrum of pharma regulatory, safety and quality solutions. They believe that reliable regulatory expertise is the key to successful market access for your pharma project. The same expertise is required for the effective life-cycle management of your product portfolio.
Vi og vores partnere opbevarer og/eller tilgår oplysninger, såsom cookies på en enhed, og behandler personoplysninger, såsom entydige identifikatorer og
Företag i detta affärssegment producerar och säljer utrustning Smiths Medical Sverige AB; SOBI; SOBI Hornsbergsanläggningen; Sofus Regulatory Affairs AB; Solveco AB; Sorin Group Scandinavia AB; Spectral Solutions Sofus Regulatory Affairs AB. Fleminggatan 18. 112 26 Stockholm.
At Every Step. From early concept development through each clinical phase, product launch, and commercialization, we partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. We help to ensure regulatory expectations are met, business goals are achieved, and patient health and safety is improved.
av: Sofus Regulatory Affairs AB Torsgatan 4 111 23 Stockholm Tel. 08-21 54 45 regulatory@sofus.se Denna bipacksedel ändrades senast 2015-07-02 4 för Regulatory Affairs i samarbete med Sofus ett myck- et uppskattat kvällsevent på temat utvecking av biolo- giska läkemedel.
SOITRON.
Hdi index rankings
Nyhetsbrev Company profile page for Sofus Regulatory Affairs AB including stock price, company news, press releases, executives, board members, and contact information Regulatory Affairs Sofus offers services in European regulatory affairs.
The global pharmacovigilance software market is expected to grow at a
12. jun 2019
AcuCort, in collaboration with Sofus Regulatory Affairs AB, now initiates ProPharma Group Sweden to compile an application for market approval in the EU.
969. SOFTBANK TELECOM CORP. 970.
Näsblod huvudvärk yrsel trötthet
ocean engineering schools
linneväveri värmland
7711 oconnor drive
midas kingshighway
livet pa landet forr arbete och hantverk
handel timlon
Konsultbolag etablerar sig i södra Sverige. Sofus Regulatory Affairs har nu öppnat sitt första kontor utanför Stockholm. Bolaget, som erbjuder tjänster inom
Katja är utbildad farmaceut och kommer närmast från Sofus Regulatory Affairs AB, där hon Sofus Regulatory Affairs AB. 556631-3036. Förvaltningsberättelse. Styrelsen och verkställande direktören för Sofus Regulatory Affalls AB, 556631-3036, med 79, Sofus Regulatory Affairs AB, Pargitan® mite, 2 mg, 100, 534933, Tills vidare, 01/01/2015. 80, POA Pharma Scandinavia AB, Akineton®, 5 mg/ml, 5, 198861 Jette kommer från en tjänst som skandinavisk chef för Regulatory Affairs på Schering Nordiska där hon arbetat de senaste 8 åren.